Palisade Bio (PALI) Shares Issued (2010 - 2026)

Palisade Bio (PALI) has 14 years of Shares Issued data on file, last reported at $3.2 million in Q1 2026.

• Quarterly Shares Issued changed N/A year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.5 million (up 2116.27% YoY) and the FY2025 annual result came in at $128.2 million, up 1420.08% from the prior year.
• Shares Issued fell to $3.2 million in Q1 2026 per PALI's latest filing, from $128.2 million in the prior quarter.
• Across five years, Shares Issued topped out at $128.2 million in Q4 2025 and bottomed at -$7.7 million in Q3 2023.
• The 5-year median for Shares Issued is $2.2 million (2023), against an average of $11.9 million.
• The widest annual swing landed in 2023, when Shares Issued tumbled 160.83%; it then soared 49452.94% in 2024.
• Tracing PALI's Shares Issued over 5 years: stood at $12.6 million in 2022, then tumbled by 99.87% to $17000.0 in 2023, then surged by 49452.94% to $8.4 million in 2024, then soared by 1422.03% to $128.2 million in 2025, then plunged by 97.47% to $3.2 million in 2026.
• Per Business Quant, the three latest PALI Shares Issued figures stand at $3.2 million (Q1 2026), $128.2 million (Q4 2025), and $2000.0 (Q3 2025).

Peer Comparison